Breathe Well Live Well
|
Nuclear Bioavailability of the Glucocorticoid Receptor in a Pediatric Asthma …
Nature.com Despite the overall effectiveness of glucocorticoids (GCs) in the treatment of asthma, a large proportion of patients do not fully respond to this medication. The objective of the present study was to investigate the potential molecular mechanisms … |
View full post on asthma – Google News
Condition: Respiratory Disorders
Interventions: Drug: Reference Montelukast; Drug: Test 1 Montelukast; Drug: Test 2 Montelukast
Sponsor: GlaxoSmithKline
Not yet recruiting – verified December 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Healthy
Interventions: Drug: Tiotropium/Salmeterol; Drug: Serevent® Diskus®; Drug: Spiriva®
Sponsor: Boehringer Ingelheim
Completed – verified September 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: terbutaline sulphate delivered dose; Drug: terbutaline sulphate metered dose
Sponsor: AstraZeneca
Not yet recruiting – verified June 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Conditions: Asthma; Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Budesonide; Drug: Procaterol
Sponsor: Intech Biopharm Ltd.
Completed – verified June 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Seretide 250(8puffs) via Evohaler actuator; Drug: Seretide 250 (8 puffs)/placebo via Volumatic spacer; Drug: Seretide 250/placebo 8 puffs via Aerochamber Plus spacer; Drug: Seretide 250/placebo via Synchro-Breathe
Sponsor: University of Dundee
Completed – verified December 2009
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days